Search

Home > News & Events > Current News

Current News

Current SATVI news

Results from innovative tuberculosis vaccine trial show potential for new BCG revaccination strategies and hope for subunit vaccines.
Thursday, July 12, 2018 - 08:15

Scientists from the South African Tuberculosis Vaccine Initiative (SATVI) and the Desmond Tutu HIV Foundation have announced publication in the New England Journal of Medicine of the results of an innovative clinical trial that provides encouraging new evidence that TB vaccines could prevent sustained TB infections in high-risk adolescents. our latest TB vaccine clinical trial have been published in the New England Journal of Medicine.

Vaccine Honours students
Wednesday, June 27, 2018 - 21:00

On Friday 22 June 2018 the Worcester SATVI field site hosted UCT Honours Vaccinology students.

Latest research: A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts
Tuesday, May 29, 2018 - 14:15

SATVI's Associate Professor Tom Scriba has co-authored a research paper titled "Latest research: A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts" appearing in the Frontiers in Immunology.

11 April 2018 SATVI 2017 Annual Report Now available
Wednesday, April 11, 2018 - 13:00

The 2017 SATVI Annual Report is now available.

Latest Research: Four-gene Pan-African Blood Signature Predicts Progression to Tuberculosis
Monday, April 9, 2018 - 14:45

Researchers at the South African Tuberculosis Vaccine Initiative have co-authored an article titled  "Four-gene Pan-African Blood Signature Predicts Progression to Tuberculosis" appearing in the American Journal of Respiratory and Critical Care Medicine.

 

Postdoctoral Vacancy: TB Vaccine Trial Immunology
Friday, April 6, 2018 - 15:00

The South African Tuberculosis Vaccine Initiative invites applications for a Postdoctoral Fellowship to conduct research on the Immunology of TB vaccines. NOW CLOSED.

Latest Research: Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial
Saturday, March 24, 2018 - 09:45

SATVI researchers have published an article titled: "Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial"  appearing in the latest Lancet Respiratory Medicine.

23 March 2018 TB under the Spotligh Science Engagement launched
Thursday, March 22, 2018 - 21:45

On the eve of World TB Day we launched the "TB under the Spotlight Science Engagement" initiative in Worcester in partnership with the Division of Molecular Biology and Human Genetics at the University Stellenbosch and the Department of Education on Tuesday 20 March 2018.

 

20 March 2018 Focus on TB: Read about fight against TB in Cape Winelands
Monday, March 19, 2018 - 19:30

Read the latest news about the fight against TB in the Cape Winelands.

20 March 2018 Focus on TB: Read about fight against TB in Cape Winelands
Monday, March 19, 2018 - 12:45

Read about news in the fight against TB. Lees nuus oor die stryd teen TB.

19 March 2018 Launch of TB under Spotlight Science Engagement
Monday, March 19, 2018 - 08:15

SATVI will be launching the "Tb Under the Spotlight Science Engagement" in partnership with the Department of Education, the SA MRC Centre for Tuberculosis Research, the DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, Division of Molecular Biology and Human Genetics, Stellenbosch University  and UCT Anthropology on Tuesday 20 March 2018 in Worcester, Stellenbosch, and Robertson.

Vacancy Research Pharmacist
Tuesday, November 21, 2017 - 12:15

We have a vacancy for a Research Pharmacist at our Worcester Field site. NOW CLOSED

Pages